Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1994 Feb;93(2):731–736. doi: 10.1172/JCI117027

Hereditary renal amyloidosis with a novel variant fibrinogen.

T Uemichi 1, J J Liepnieks 1, M D Benson 1
PMCID: PMC293912  PMID: 8113408

Abstract

Two families with hereditary renal amyloidosis were found to have a novel mutation in the fibrinogen A alpha chain gene. This form of amyloidosis is an autosomal dominant condition characterized by proteinuria, hypertension, and subsequent azotemia. DNAs of patients with amyloidosis were screened for a polymorphism in fibrinogen A alpha chain gene by single-strand conformation polymorphism analysis, and affected individuals from two kindreds were found to have a mutation. Both of these kindreds are American of Irish descent presenting with non-neuropathic, nephropathic amyloidosis in the fifth to the seventh decade of life. DNA sequencing showed a point mutation in the fibrinogen A alpha chain gene that is responsible for substitution of valine for glutamic acid at position 526. By restriction fragment length polymorphism analysis, 7 affected individuals and 14 asymptomatic individuals in these two kindreds were positive for the fibrinogen A alpha chain Val 526 gene. Fibrinogen was isolated from plasma of a heterozygous gene carrier and shown to contain approximately 50% variant fibrinogen. Discovery of this new mutation confirms the association between fibrinogen A alpha chain variant and hereditary renal amyloidosis and establishes a new biochemical subtype of amyloidosis.

Full text

PDF
731

Images in this article

733Image
on p.733
734Image
on p.734
734Image
on p.734
734Image
on p.734

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alexander F., Atkins E. L. Familial renal amyloidosis. Case reports, literature review and classification. Am J Med. 1975 Jul;59(1):121–128. doi: 10.1016/0002-9343(75)90329-0. [DOI] [PubMed] [Google Scholar]
  2. Benson M. D. Inherited amyloidosis. J Med Genet. 1991 Feb;28(2):73–78. doi: 10.1136/jmg.28.2.73. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Benson M. D., Liepnieks J., Uemichi T., Wheeler G., Correa R. Hereditary renal amyloidosis associated with a mutant fibrinogen alpha-chain. Nat Genet. 1993 Mar;3(3):252–255. doi: 10.1038/ng0393-252. [DOI] [PubMed] [Google Scholar]
  4. CLAUSS A. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haematol. 1957 Apr;17(4):237–246. doi: 10.1159/000205234. [DOI] [PubMed] [Google Scholar]
  5. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 50-1987. A 43-year-old woman with hepatic failure after renal transplantation because of amyloidosis. N Engl J Med. 1987 Dec 10;317(24):1520–1531. doi: 10.1056/NEJM198712103172407. [DOI] [PubMed] [Google Scholar]
  6. Chartier-Harlin M. C., Crawford F., Houlden H., Warren A., Hughes D., Fidani L., Goate A., Rossor M., Roques P., Hardy J. Early-onset Alzheimer's disease caused by mutations at codon 717 of the beta-amyloid precursor protein gene. Nature. 1991 Oct 31;353(6347):844–846. doi: 10.1038/353844a0. [DOI] [PubMed] [Google Scholar]
  7. Chung D. W., Harris J. E., Davie E. W. Nucleotide sequences of the three genes coding for human fibrinogen. Adv Exp Med Biol. 1990;281:39–48. doi: 10.1007/978-1-4615-3806-6_3. [DOI] [PubMed] [Google Scholar]
  8. Deutsch D. G., Mertz E. T. Plasminogen: purification from human plasma by affinity chromatography. Science. 1970 Dec 4;170(3962):1095–1096. doi: 10.1126/science.170.3962.1095. [DOI] [PubMed] [Google Scholar]
  9. Doolittle R. F., Watt K. W., Cottrell B. A., Strong D. D., Riley M. The amino acid sequence of the alpha-chain of human fibrinogen. Nature. 1979 Aug 9;280(5722):464–468. doi: 10.1038/280464a0. [DOI] [PubMed] [Google Scholar]
  10. Dwulet F. E., Benson M. D. Characterization of a transthyretin (prealbumin) variant associated with familial amyloidotic polyneuropathy type II (Indiana/Swiss). J Clin Invest. 1986 Oct;78(4):880–886. doi: 10.1172/JCI112675. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Dwulet F. E., Benson M. D. Polymorphism of human plasma thyroxine binding prealbumin. Biochem Biophys Res Commun. 1983 Jul 29;114(2):657–662. doi: 10.1016/0006-291x(83)90831-8. [DOI] [PubMed] [Google Scholar]
  12. Dwulet F. E., Benson M. D. Primary structure of an amyloid prealbumin and its plasma precursor in a heredofamilial polyneuropathy of Swedish origin. Proc Natl Acad Sci U S A. 1984 Feb;81(3):694–698. doi: 10.1073/pnas.81.3.694. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Engvall E., Ruoslahti E. Binding of soluble form of fibroblast surface protein, fibronectin, to collagen. Int J Cancer. 1977 Jul 15;20(1):1–5. doi: 10.1002/ijc.2910200102. [DOI] [PubMed] [Google Scholar]
  14. Ghiso J., Pons-Estel B., Frangione B. Hereditary cerebral amyloid angiopathy: the amyloid fibrils contain a protein which is a variant of cystatin C, an inhibitor of lysosomal cysteine proteases. Biochem Biophys Res Commun. 1986 Apr 29;136(2):548–554. doi: 10.1016/0006-291x(86)90475-4. [DOI] [PubMed] [Google Scholar]
  15. Goate A., Chartier-Harlin M. C., Mullan M., Brown J., Crawford F., Fidani L., Giuffra L., Haynes A., Irving N., James L. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature. 1991 Feb 21;349(6311):704–706. doi: 10.1038/349704a0. [DOI] [PubMed] [Google Scholar]
  16. Koopman J., Haverkate F., Grimbergen J., Egbring R., Lord S. T. Fibrinogen Marburg: a homozygous case of dysfibrinogenemia, lacking amino acids A alpha 461-610 (Lys 461 AAA-->stop TAA). Blood. 1992 Oct 15;80(8):1972–1979. [PubMed] [Google Scholar]
  17. Koopman J., Haverkate F., Grimbergen J., Lord S. T., Mosesson M. W., DiOrio J. P., Siebenlist K. S., Legrand C., Soria J., Soria C. Molecular basis for fibrinogen Dusart (A alpha 554 Arg-->Cys) and its association with abnormal fibrin polymerization and thrombophilia. J Clin Invest. 1993 Apr;91(4):1637–1643. doi: 10.1172/JCI116371. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Lanham J. G., Meltzer M. L., De Beer F. C., Hughes G. R., Pepys M. B. Familial amyloidosis of Ostertag. Q J Med. 1982;51(201):25–32. [PubMed] [Google Scholar]
  19. Levy E., Carman M. D., Fernandez-Madrid I. J., Power M. D., Lieberburg I., van Duinen S. G., Bots G. T., Luyendijk W., Frangione B. Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. Science. 1990 Jun 1;248(4959):1124–1126. doi: 10.1126/science.2111584. [DOI] [PubMed] [Google Scholar]
  20. Levy E., Haltia M., Fernandez-Madrid I., Koivunen O., Ghiso J., Prelli F., Frangione B. Mutation in gelsolin gene in Finnish hereditary amyloidosis. J Exp Med. 1990 Dec 1;172(6):1865–1867. doi: 10.1084/jem.172.6.1865. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Liepnieks J. J., Dwulet F. E., Benson M. D. Amino acid sequence of a kappa I primary (AL) amyloid protein (AND). Mol Immunol. 1990 Jun;27(6):481–485. doi: 10.1016/0161-5890(90)90066-9. [DOI] [PubMed] [Google Scholar]
  22. Madisen L., Hoar D. I., Holroyd C. D., Crisp M., Hodes M. E. DNA banking: the effects of storage of blood and isolated DNA on the integrity of DNA. Am J Med Genet. 1987 Jun;27(2):379–390. doi: 10.1002/ajmg.1320270216. [DOI] [PubMed] [Google Scholar]
  23. Mancini G., Carbonara A. O., Heremans J. F. Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry. 1965 Sep;2(3):235–254. doi: 10.1016/0019-2791(65)90004-2. [DOI] [PubMed] [Google Scholar]
  24. Maury C. P., Kere J., Tolvanen R., de la Chapelle A. Finnish hereditary amyloidosis is caused by a single nucleotide substitution in the gelsolin gene. FEBS Lett. 1990 Dec 10;276(1-2):75–77. doi: 10.1016/0014-5793(90)80510-p. [DOI] [PubMed] [Google Scholar]
  25. Mornaghi R., Rubinstein P., Franklin E. C. Familial renal amyloidosis: case reports and genetic studies. Am J Med. 1982 Oct;73(4):609–614. doi: 10.1016/0002-9343(82)90342-4. [DOI] [PubMed] [Google Scholar]
  26. Mornaghi R., Rubinstein P., Franklin E. C. Studies on the pathogenesis of a familial form of renal amyloidosis. Trans Assoc Am Physicians. 1981;94:211–216. [PubMed] [Google Scholar]
  27. Murrell J., Farlow M., Ghetti B., Benson M. D. A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease. Science. 1991 Oct 4;254(5028):97–99. doi: 10.1126/science.1925564. [DOI] [PubMed] [Google Scholar]
  28. Nichols W. C., Gregg R. E., Brewer H. B., Jr, Benson M. D. A mutation in apolipoprotein A-I in the Iowa type of familial amyloidotic polyneuropathy. Genomics. 1990 Oct;8(2):318–323. doi: 10.1016/0888-7543(90)90288-6. [DOI] [PubMed] [Google Scholar]
  29. Nichols W. C., Liepnieks J. J., McKusick V. A., Benson M. D. Direct sequencing of the gene for Maryland/German familial amyloidotic polyneuropathy type II and genotyping by allele-specific enzymatic amplification. Genomics. 1989 Oct;5(3):535–540. doi: 10.1016/0888-7543(89)90020-7. [DOI] [PubMed] [Google Scholar]
  30. Orita M., Suzuki Y., Sekiya T., Hayashi K. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics. 1989 Nov;5(4):874–879. doi: 10.1016/0888-7543(89)90129-8. [DOI] [PubMed] [Google Scholar]
  31. Pepys M. B., Hawkins P. N., Booth D. R., Vigushin D. M., Tennent G. A., Soutar A. K., Totty N., Nguyen O., Blake C. C., Terry C. J. Human lysozyme gene mutations cause hereditary systemic amyloidosis. Nature. 1993 Apr 8;362(6420):553–557. doi: 10.1038/362553a0. [DOI] [PubMed] [Google Scholar]
  32. Siebenlist K. R., Mosesson M. W., DiOrio J. P., Soria J., Soria C., Caen J. P. The polymerization of fibrinogen Dusart (A alpha 554 Arg-->Cys) after removal of carboxy terminal regions of the A alpha-chains. Blood Coagul Fibrinolysis. 1993 Feb;4(1):61–65. [PubMed] [Google Scholar]
  33. Soutar A. K., Hawkins P. N., Vigushin D. M., Tennent G. A., Booth S. E., Hutton T., Nguyen O., Totty N. F., Feest T. G., Hsuan J. J. Apolipoprotein AI mutation Arg-60 causes autosomal dominant amyloidosis. Proc Natl Acad Sci U S A. 1992 Aug 15;89(16):7389–7393. doi: 10.1073/pnas.89.16.7389. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Tawara S., Nakazato M., Kangawa K., Matsuo H., Araki S. Identification of amyloid prealbumin variant in familial amyloidotic polyneuropathy (Japanese type). Biochem Biophys Res Commun. 1983 Nov 15;116(3):880–888. doi: 10.1016/s0006-291x(83)80224-1. [DOI] [PubMed] [Google Scholar]
  35. Uemichi T., Murrell J. R., Zeldenrust S., Benson M. D. A new mutant transthyretin (Arg 10) associated with familial amyloid polyneuropathy. J Med Genet. 1992 Dec;29(12):888–891. doi: 10.1136/jmg.29.12.888. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Weiss S. H., Page D. L. Amyloid nephropathy of Ostertag: report of a kindred. Birth Defects Orig Artic Ser. 1974;10(4):67–68. [PubMed] [Google Scholar]
  37. Weiss S. W., Page D. L. Amyloid nephropathy of Ostertag with special reference to renal glomerular giant cells. Am J Pathol. 1973 Sep;72(3):447–460. [PMC free article] [PubMed] [Google Scholar]
  38. Zalin A. M., Jones S., Fitch N. J., Ramsden D. B. Familial nephropathic non-neuropathic amyloidosis: clinical features, immunohistochemistry and chemistry. Q J Med. 1991 Nov;81(295):945–956. [PubMed] [Google Scholar]
  39. de la Chapelle A., Tolvanen R., Boysen G., Santavy J., Bleeker-Wagemakers L., Maury C. P., Kere J. Gelsolin-derived familial amyloidosis caused by asparagine or tyrosine substitution for aspartic acid at residue 187. Nat Genet. 1992 Oct;2(2):157–160. doi: 10.1038/ng1092-157. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES